# SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia

> **NCT00060099** · PHASE2 · UNKNOWN · sponsor: **Dana-Farber/Brigham and Women's Cancer Center**

## Conditions studied

- Precancerous Condition

## Interventions

- **BIOLOGICAL:** HspE7

## Key facts

- **NCT ID:** NCT00060099
- **Lead sponsor:** Dana-Farber/Brigham and Women's Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060099, "SGN-00101 in Treating Patients With Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00060099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*